Archives

In Recognition of National Peripheral Artery Disease (PAD) Awareness Month, THE SAGE GROUP Highlights Gender Disparities in PAD

According to THE SAGE GROUP, High Restenosis Rates Following Endovascular Treatment of Infrapopliteal Disease Create a Significant Need for Improved Technologies

THE SAGE GROUP Comments on National Peripheral Artery Disease (PAD) Awareness Month

THE SAGE GROUP Announces a New Publication on Peripheral Artery Disease in African Americans

In Honor of National Peripheral Artery Disease (PAD) Awareness Month, THE SAGE GROUP Comments on the Costs and Consequences of the Amputation Lottery

According to THE SAGE GROUP, Restenosis Remains a Significant and Costly Problem After Endovascular Treatment of Peripheral Artery Disease (PAD)

According to THE SAGE GROUP, Treating Critical Limb Ischemia (CLI) with Major Amputation Costs Over $22 Billion, Results in a Significant Misallocation of Healthcare Resources and Wastes Taxpayer Dollars.

THE SAGE GROUP Announces a New Publication Titled “Critical Limb Ischemia (CLI) Non-Responders: Patients Who Do Not Respond to Revascularization, Factors That Identify Non-response and Non-Responder Prevalence and Markets.”

According to THE SAGE GROUP, the Annual Ecnomic Burden of Critical Limb Ischemia (CLI) Exceeds $200 Billion.

According to THE SAGE GROUP, Critical Limb Ischemia (CLI) is a Major and Growing Problem.

According to THE SAGE GROUP, Thrombus is Highly Prevalent in Both Symptomatic and Asymptomatic Peripheral Artery Disease (PAD) Patients.

THE SAGE GROUP Announces Publication of U.S. Acute Limb Ischemia (ALI) Incidence and Market Estimates.

According to THE SAGE GROUP, 10.8 Million Women in the United States Have Peripheral Artery Disease (PAD) While Over 40 Million Have Chronic Venous Disease (CVD).

According to THE SAGE GROUP LLC, Peripheral Artery Disease (PAD) Afflicts 41 to 54 Million Indian Citizens.

THE SAGE GROUP Announces Publication of Estimates of Critical Limb Ischemia (CLI) Prevalence by Rutherford Category.